| Year |
Citation |
Score |
| 2019 |
Siret C, Collignon A, Silvy F, Robert S, Cheyrol T, André P, Rigot V, Iovanna J, van de Pavert S, Lombardo D, Mas E, Martirosyan A. Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma. Frontiers in Immunology. 10: 3070. PMID 32038621 DOI: 10.3389/Fimmu.2019.03070 |
0.379 |
|
| 2010 |
Wong WW, Boutros PC, Wasylishen AR, Guckert KD, O'Brien EM, Griffiths R, Martirosyan AR, Bros C, Jurisica I, Langler RF, Penn LZ. Characterization of the apoptotic response of human leukemia cells to organosulfur compounds. Bmc Cancer. 10: 351. PMID 20598143 DOI: 10.1186/1471-2407-10-351 |
0.304 |
|
| 2010 |
Clendening JW, Pandyra A, Li Z, Boutros PC, Martirosyan A, Lehner R, Jurisica I, Trudel S, Penn LZ. Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma. Blood. 115: 4787-97. PMID 20360469 DOI: 10.1182/Blood-2009-07-230508 |
0.378 |
|
| 2007 |
Wong WW, Clendening JW, Martirosyan A, Boutros PC, Bros C, Khosravi F, Jurisica I, Stewart AK, Bergsagel PL, Penn LZ. Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma. Molecular Cancer Therapeutics. 6: 1886-97. PMID 17575117 DOI: 10.1158/1535-7163.Mct-06-0745 |
0.331 |
|
| 2004 |
Martirosyan AR, Rahim-Bata R, Freeman AB, Clarke CD, Howard RL, Strobl JS. Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model. Biochemical Pharmacology. 68: 1729-38. PMID 15450938 DOI: 10.1016/j.bcp.2004.05.003 |
0.4 |
|
| 2002 |
Melkoumian ZK, Martirosyan AR, Strobl JS. Myc protein is differentially sensitive to quinidine in tumor versus immortalized breast epithelial cell lines. International Journal of Cancer. 102: 60-9. PMID 12353235 DOI: 10.1002/ijc.10648 |
0.326 |
|
| Show low-probability matches. |